S100A7 and cutaneous melanoma: S100A7 expression was closely related to the overall survival of patients with skin cutaneous melanoma (Figure 2B), kidney renal clear cell carcinoma (Figure 2C), liver hepatocellular carcinoma (Figure 2D), and the disease-specific survival of patients with kidney renal clear cell carcinoma (Figure 2E) and skin cutaneous melanoma (Figure 2F).